COMMUNIQUÉS West-GlobeNewswire

-
Korro to Participate in Upcoming Investor Conferences
21/11/2024 -
Inventiva reports 2024 Third Quarter Financial Information¹
21/11/2024 -
Inventiva publie ses informations financières du 3ème trimestre 2024¹
21/11/2024 -
Tevogen Bio CEO Reflects on Public Support, Reaffirms Preserving Shareholder Value Remains His Priority, and Reinforces Options Including a Potential Share Buyback to Support Company Value
21/11/2024 -
Grant of Restricted Stock Units and Warrants to Employees in Genmab
21/11/2024 -
Light-it Launches CompliantChatGPT v2: Advanced AI Solutions to Reduce Medical Burden and Streamline Healthcare Workflows
21/11/2024 -
Bio Usawa and Rwandan Government Sign a Memorandum of Understanding to Manufacture Affordable Biologics in Africa
21/11/2024 -
Delaware North forms robust partnership with Birches Health to power new responsible gaming initiatives
21/11/2024 -
AscellaHealth Ranked Number 154 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™
21/11/2024 -
Chromocell Announces Name Change to “Channel Therapeutics Corporation” and Provides Therapeutic Program Updates
21/11/2024 -
Positron Corporation Partners With Upbeat Cardiology Solutions to Expand Cardiac PET-CT Offerings
21/11/2024 -
Aeroflow Health Celebrates Nevada’s Elimination of the Diaper Tax
21/11/2024 -
Gaurav Agarwal Joins Capsa Healthcare as Chief Executive Officer to Lead Next Innovative Growth Phase
21/11/2024 -
DANNCE.AI Raises $2.6 Million; Launches to Provide Clinicians and Drug Developers an AI Biomarkers Platform to Characterize Drug Effects and Optimize Neurological Care
21/11/2024 -
Bright Minds Biosciences to Present Data at the American Epilepsy Society 2024 Annual Meeting
21/11/2024 -
Updated Phase 2 OraGrowtH Data Presented at ESPE 2024 Demonstrate Sustained Growth on Oral LUM-201 to 24 Months in PGHD and Correlation of Growth to LUM-201’s Unique Pulsatile Mechanism of Action
21/11/2024 -
Vilya Announces Exclusive License Agreement of RFdiffusion-based Generative Model from the University of Washington for the Design of Macrocyclic Peptides
21/11/2024 -
Bluejay Therapeutics Announces Expansion of Leadership Team and Board of Directors
21/11/2024 -
NEXGEL to Participate in the iAccess Alpha Virtual Best Ideas Winter Conference on December 10-11, 2024
21/11/2024
Pages